More Books:

Royalty Rates in Biotech
Language: en
Pages: 542
Authors: Valuation Business Valuation Resources, Business Valuation Resources
Categories: Business & Economics
Type: BOOK - Published: 2010-05-01 - Publisher: Business Valuation Resources

A collection of actual licenscing agreements for the Biotech industry, this book makes an excellent benchmarking tool for companies looking to license their technology.
Biotechnology and the Law
Language: en
Pages: 957
Authors: Hugh B. Wellons, Eileen Smith Ewing
Categories: Law
Type: BOOK - Published: 2007 - Publisher: American Bar Association

The book is written to help lawyers faced with the challenge of identifying the legal issues and processes that must be faced by their clients in building, marketing, and protecting a biotech business. The contributors are experts in this specialized area and provide thorough, yet accessible, overviews of biotech subspecialties
Economic Damages in Intellectual Property
Language: en
Pages: 352
Authors: Daniel Slottje
Categories: Law
Type: BOOK - Published: 2006-11-28 - Publisher: John Wiley & Sons

Insider Information at Your Fingertips Determining the worth of intellectual property (IP) is a complicated task. An IP litigator needs to conclude the monetary damage occurring as a result of harm done to an inventor's or a company's reputation as well as the economic damage caused by compromise of an
Introduction to Biotechnology
Language: en
Pages: 382
Authors: Ravi Pathak
Categories: Biotechnology
Type: BOOK - Published: 2007 - Publisher: Atlantic Publishers & Dist

Biotechnology Is Gaining In Importance In The Modern World And Is Often Quoted As The Next Big Thing After Information Technology, Owing To Its Benefits To Man. It Has Enabled The Organisms To Become More Resistant To Disease, Influenced The Rate Of Fruit Ripening And Has Increased Productivity Of Crops,
Valuation in Life Sciences
Language: en
Pages: 334
Authors: Boris Bogdan, Ralph Villiger
Categories: Business & Economics
Type: BOOK - Published: 2008-03-29 - Publisher: Springer Science & Business Media

This is the first complete guide to valuation in life sciences for industry professionals, investors, and academics. Boris Bogdan and Ralph Villiger introduce the characteristics of drug and medical device development, explain how to translate these into the valuation, and provide valuable industry data. Special emphasis is put on the